Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 167

1.

Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.

Wong ET, Timmons J, Callahan A, O'Loughlin L, Giarusso B, Alsop DC.

BMC Cancer. 2016 Nov 22;16(1):914.

2.

Evaluation of the Tobacco Heating System 2.2 (THS2.2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke.

Sewer A, Kogel U, Talikka M, Wong ET, Martin F, Xiang Y, Guedj E, Ivanov NV, Hoeng J, Peitsch MC.

Regul Toxicol Pharmacol. 2016 Nov 17. pii: S0273-2300(16)30362-2. doi: 10.1016/j.yrtph.2016.11.018. [Epub ahead of print]

3.

Evaluation of the Tobacco Heating System 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke.

Wong ET, Kogel U, Veljkovic E, Martin F, Xiang Y, Boue S, Vuillaume G, Leroy P, Guedj E, Rodrigo G, Ivanov NV, Hoeng J, Peitsch MC, Vanscheeuwijck P.

Regul Toxicol Pharmacol. 2016 Oct 26. pii: S0273-2300(16)30304-X. doi: 10.1016/j.yrtph.2016.10.015. [Epub ahead of print]

4.

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.

Timmons JJ, Cohessy S, Wong ET.

J Vis Exp. 2016 May 24;(111). doi: 10.3791/54039.

5.

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Lee EQ, Muzikansky A, Drappatz J, Kesari S, Wong ET, Fadul CE, Reardon DA, Norden AD, Nayak L, Rinne ML, Alexander BM, Arvold ND, Doherty L, Stefanik J, LaFrankie D, Ruland SF, Pulverenti J, Smith KH, Gaffey SC, Hammond S, Wen PY.

Neuro Oncol. 2016 Jun;18(6):849-54. doi: 10.1093/neuonc/now007.

PMID:
26902850
6.

Technological Advances in the Treatment of Cancer: Combining Modalities to Optimize Outcomes.

Wong ET, Toms SA, Ahluwalia MS.

Clin Adv Hematol Oncol. 2015 Nov;13(11 Suppl 11):1-18.

PMID:
26862770
7.

Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients.

Fonkem E, Dayawansa S, Stroberg E, Lok E, Bricker PC, Kirmani B, Wong ET, Huang JH.

BMC Neurol. 2016 Jan 16;16:9. doi: 10.1186/s12883-015-0509-8.

8.

An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma.

Swanson KD, Lok E, Wong ET.

Curr Neurol Neurosci Rep. 2016 Jan;16(1):8. doi: 10.1007/s11910-015-0606-5. Review.

9.

Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection.

Ippen FM, Mahadevan A, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM.

J Oncol. 2015;2015:636918. doi: 10.1155/2015/636918.

10.

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.

Wong ET, Lok E, Gautam S, Swanson KD.

Br J Cancer. 2015 Dec 1;113(11):1642. doi: 10.1038/bjc.2015.404. No abstract available.

11.

Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.

Mahadevan A, Sampson C, LaRosa S, Floyd SR, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM.

Radiat Oncol. 2015 Nov 26;10:245. doi: 10.1186/s13014-015-0555-9.

12.

Computational Identification of MoRFs in Protein Sequences Using Hierarchical Application of Bayes Rule.

Malhis N, Wong ET, Nassar R, Gsponer J.

PLoS One. 2015 Oct 30;10(10):e0141603. doi: 10.1371/journal.pone.0141603.

13.

Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations.

Lok E, Swanson KD, Wong ET.

Expert Rev Med Devices. 2015;12(6):717-26. doi: 10.1586/17434440.2015.1086641. Review.

PMID:
26513694
14.

Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery.

Lai G, Mahadevan A, Hackney D, Warnke PC, Nigim F, Kasper E, Wong ET, Carter BS, Chen CC.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2250-5. doi: 10.3174/ajnr.A4475.

15.

Stereotactic radiosurgery for brain metastases from malignant melanoma.

Christ SM, Mahadevan A, Floyd SR, Lam FC, Chen CC, Wong ET, Kasper EM.

Surg Neurol Int. 2015 Aug 20;6(Suppl 12):S355-65. doi: 10.4103/2152-7806.163315.

16.

Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'.

Wong ET, Swanson KD.

Br J Cancer. 2015 Dec 1;113(11):1633-4. doi: 10.1038/bjc.2015.320. No abstract available.

17.

Computed modeling of alternating electric fields therapy for recurrent glioblastoma.

Lok E, Hua V, Wong ET.

Cancer Med. 2015 Nov;4(11):1697-9. doi: 10.1002/cam4.519.

18.

An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas.

Wong ET, Lok E, Swanson KD.

Curr Treat Options Oncol. 2015 Aug;16(8):40. doi: 10.1007/s11864-015-0353-5. Review.

19.

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.

Wong ET, Lok E, Gautam S, Swanson KD.

Br J Cancer. 2015 Jul 14;113(2):232-41. doi: 10.1038/bjc.2015.238. Erratum in: Br J Cancer. 2015 Dec 1;113(11):1642.

20.

Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit.

Gera N, Yang A, Holtzman TS, Lee SX, Wong ET, Swanson KD.

PLoS One. 2015 May 26;10(5):e0125269. doi: 10.1371/journal.pone.0125269.

Items per page

Supplemental Content

Support Center